Sionna Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SION and other ETFs, options, and stocks.About SION
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis.
CEOMichael Cloonan
CEOMichael Cloonan
Employees41
Employees41
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2019
Founded2019
Employees41
Employees41
SION Key Statistics
Market cap1.76B
Market cap1.76B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume446.20K
Average volume446.20K
High today$40.39
High today$40.39
Low today$38.68
Low today$38.68
Open price$40.33
Open price$40.33
Volume518.71K
Volume518.71K
52 Week high$43.20
52 Week high$43.20
52 Week low$7.26
52 Week low$7.26
SION News
TipRanks 5d
Sionna Therapeutics announces initiation of PreciSION CF Phase 2a trialSionna Therapeutics (SION) announced initiation of the PreciSION CF Phase 2a proof-of-concept trial evaluating SION-719, a first-in-class nucleotide binding dom...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own SION. This list is generated using Robinhood data, and it’s not a recommendation.